Citations for
1KCNIP3, PSEN1
Molecular insight of DREAM and presenilin 1 C-terminal fragment interactions.
Pham K, Miksovska J.
FEBS Lett 590(8):1114-22. doi: 10.1002/1873-3468.12156. Epub 2016 Apr 8. 2016
2KCNIP3
Decreased Expression of DREAM Promotes the Degeneration of Retinal Neurons.
Chintala S, Cheng M, Zhang X.
PLoS One 10(5):e0127776. doi: 10.1371/journal.pone.0127776. eCollection 2015. 2015
3KCNIP3, TNFAIP3
The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation.
Tiruppathi C, Soni D, Wang DM, Xue J, Singh V, Thippegowda PB, Cheppudira BP, Mishra RK, Debroy A, Qian Z, Bachmaier K, Zhao YY, Christman JW, Vogel SM, Ma A, Malik AB.
Nat Immunol 15(3):239-47. doi: 10.1038/ni.2823. Epub 2014 Feb 2. 2014
4KCNIP3
DREAM controls the on/off switch of specific activity-dependent transcription pathways.
Mellström B, Sahún I, Ruiz-Nuńo A, Murtra P, Gomez-Villafuertes R, Savignac M, Oliveros JC, Gonzalez P, Kastanauskaite A, Knafo S, Zhuo M, Higuera-Matas A, Errington ML, Maldonado R, DeFelipe J, Jefferys JG, Bliss TV, Dierssen M, Naranjo JR.
Mol Cell Biol 34(5):877-87. doi: 10.1128/MCB.00360-13. Epub 2013 Dec 23. 2014
5GCM1, KCNIP3
DREAM mediated regulation of GCM1 in the human placental trophoblast.
Baczyk D, Kibschull M, Mellstrom B, Levytska K, Rivas M, Drewlo S, Lye SJ, Naranjo JR, Kingdom JC.
PLoS One 8(1):e51837. doi: 10.1371/journal.pone.0051837. Epub 2013 Jan 3. 2013
6HK1, KCNIP3
The regulation of apoptosis by the downstream regulatory element antagonist modulator/potassium channel interacting protein 3 (DREAM/KChIP3) through interactions with hexokinase I.
Craig TA, Ramachandran PL, Bergen HR 3rd, Podratz JL, Windebank AJ, Kumar R.
Biochem Biophys Res Commun 433(4):508-12. doi: 10.1016/j.bbrc.2013.03.016. Epub 2013 Mar 21. 2013
7KCNIP3
Calsenilin contributes to neuronal cell death in ischemic stroke.
Park JS, Manzanero S, Chang JW, Choi Y, Baik SH, Cheng YL, Li YI, Gwon AR, Woo HN, Jang J, Choi IY, Lee JY, Jung YK, Tang SC, Sobey CG, Arumugam TV, Jo DG.
Brain Pathol 23(4):402-12. doi: 10.1111/bpa.12013. Epub 2012 Dec 27. 2013
8GAS2L3, KCNIP3
GAS2L3, a novel target gene of the dream complex, is required for proper cytokinesis and genomic stability.
Wolter P, Schmitt K, Fackler M, Kremling H, Probst L, Hauser S, Gruss OJ, Gaubatz S.
J Cell Sci Cell Sci. 2012 Feb 17. [Epub ahead of print] 2012
9CANT1, KCNIP3
Ca2+-activated nucleotidase 1, a novel target gene for the transcriptional repressor DREAM (downstream regulatory element antagonist modulator), is involved in protein folding and degradation.
Calě T, Fedrizzi L, Ottolini D, Gomez-Villafuertes R, Mellström B, Naranjo JR, Carafoli E, Brini M.
J Biol Chem 287(22):18478-91. doi: 10.1074/jbc.M111.304733. Epub 2012 Mar 26. 2012
10CALM1, KCNIP3
The potassium channel interacting protein 3 (DREAM/KChIP3) heterodimerizes with and regulates calmodulin function.
Ramachandran PL, Craig TA, Atanasova EA, Cui G, Owen BA, Bergen HR 3rd, Mer G, Kumar R.
J Biol Chem 287(47):39439-48. doi: 10.1074/jbc.M112.398495. Epub 2012 Sep 27. 2012
11KCNC1, KCNIP3
Expression and high glucose-mediated regulation of K+ channel interacting protein 3 (KChIP3) and KV4 channels in retinal Müller glial cells.
Chavira-Suárez E, Sandoval A, Felix R, Lamas M.
Biochem Biophys Res Commun 404(2):678-83. Epub 2010 Dec 11. 2011
12KCNIP3
Calsenilin is degraded by the ubiquitin-proteasome pathway.
Jang C, Choi JK, Kim E, Park ES, Wasco W, Buxbaum JD, Kim YS, Choi EK.
Biochem Biophys Res Commun 405(2):180-5. Epub 2011 Jan 7. 2011
13KCNIP2, KCNIP3, KCNIP4
Interdependent roles for accessory KChIP2, KChIP3, and KChIP4 subunits in the generation of Kv4-encoded IA channels in cortical pyramidal neurons.
Norris AJ, Foeger NC, Nerbonne JM.
J Neurosci 30(41):13644-55.PMID: 20943905 2010
14KCNIP3
The DREAM protein is associated with thyroid enlargement and nodular development.
Rivas M, Mellström B, Torres B, Cali G, Ferrara AM, Terracciano D, Zannini M, Morreale de Escobar G, Naranjo JR.
Mol Endocrinol 23(6):862-70. Epub 2009 Mar 19.PMID: 19299442 2009
15KCNIP3
Lack of DREAM protein enhances learning and memory and slows brain aging.
Fontán-Lozano A, Romero-Granados R, del-Pozo-Martín Y, Suárez-Pereira I, Delgado-García JM, Penninger JM, Carrión AM.
Curr Biol 19(1):54-60. Epub 2008 Dec 24. Erratum in: Curr Biol. 2009 Aug 11;19(15):1332. PMID: 19110430 2009
16ADCYAP1, KCNIP3
PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.
Vallejo M.
Mol Neurobiol 39(2):90-100. Epub 2009 Feb 24. Review.PMID: 19238593 2009
17KCNIP2, KCNIP3, KCNIP4
Multiple Kv channel-interacting proteins contain an N-terminal transmembrane domain that regulates Kv4 channel trafficking and gating.
Jerng HH, Pfaffinger PJ.
J Biol Chem 283(51):36046-59. Epub 2008 Oct 28.PMID: 18957440 2008
18KCNIP1, KCNIP2, KCNIP3, KCNIP4
Specific effects of KChIP3/calsenilin/DREAM, but not KChIPs 1, 2 and 4, on calcium signalling and regulated secretion in PC12 cells.
Venn N, Haynes LP, Burgoyne RD.
Biochem J 413(1):71-80.PMID: 18393943 2008
19KCNIP3
Interplay of the Ca2+-binding protein DREAM with presenilin in neuronal Ca2+ signaling.
Fedrizzi L, Lim D, Carafoli E, Brini M.
J Biol Chem 283(41):27494-503. Epub 2008 Jul 29.PMID: 18664571 2008
20KCNIP3
Characterization of subcellular localization and Ca2+ modulation of calsenilin/DREAM/KChIP3.
Woo HN, Chang JW, Choi YH, Gwon AR, Jung YK, Jo DG.
Neuroreport 19(12):1193-7.PMID: 18628663 2008
21KCNIP3
DREAM mediates cAMP-dependent, Ca2+-induced stimulation of GFAP gene expression and regulates cortical astrogliogenesis.
Cebolla B, Fernández-Pérez A, Perea G, Araque A, Vallejo M.
J Neurosci 28(26):6703-13.PMID: 18579744 2008
22KCNIP3
NMR structure of DREAM: Implications for Ca(2+)-dependent DNA binding and protein dimerization.
Lusin JD, Vanarotti M, Li C, Valiveti A, Ames JB.
Biochemistry 47(8):2252-64. Epub 2008 Jan 18.PMID: 18201103 2008
23CLN3, KCNIP3
Neuronal vulnerability of CLN3 deletion to calcium-induced cytotoxicity is mediated by calsenilin.
Chang JW, Choi H, Kim HJ, Jo DG, Jeon YJ, Noh JY, Park WJ, Jung YK.
Hum Mol Genet 16(3):317-26. Epub 2006 Dec 22. 2007
24KCNIP3
Solution structure and calcium-binding properties of EF-hands 3 and 4 of calsenilin.
Yu L, Sun C, Mendoza R, Wang J, Matayoshi ED, Hebert E, Pereda-Lopez A, Hajduk PJ, Olejniczak ET.
Protein Sci 16(11):2502-9.PMID: 17962406 2007
25KCNIP4, KCNIP2, KCNIP1, KCNIP3
Structure, alternative splicing, and expression of the human and mouse KCNIP gene family.
Pruunsild P, Timmusk T.
Genomics 86(5):581-93. Epub 2005 Aug 19. 2005
26KCNIP3
Genomic structure, expression pattern, and chromosomal localization of the human calsenilin gene: no association between an exonic polymorphism and Alzheimer's disease.
Buxbaum JD, Lilliehook C, Chan JY, Go RC, Bassett SS, Tanzi RE, Wasco W, Blacker D.
Neurosci Lett 294(3):135-8. 2000
27KCNIP3
Calsenilin reverses presenilin-mediated enhancement of calcium signaling.
Leissring MA, Yamasaki TR, Wasco W, Buxbaum JD, Parker I, LaFerla FM.
Proc Natl Acad Sci U S A 97(15):8590-3. 2000
28KCNIP3
DREAM is a Ca2+-regulated transcriptional repressor.
Carrion AM, Link WA, Ledo F, Mellstrom B, Naranjo JR.
Nature 398(6722):80-4. 1999